Advertisement Hologic announces public offering of convertible senior notes - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Hologic announces public offering of convertible senior notes

Medical device company Hologic has announced its intention to offer to sell, subject to market and other conditions, $1.3 billion aggregate principal amount of convertible senior notes due 2037.

Hologic expects to grant to the underwriters an option to purchase up to an additional $195 million aggregate principal amount of notes to cover over-allotments. Goldman, Sachs & Co. is acting as sole book-running manager of the offering.

The company intends to use the net proceeds from the offering to repay a portion of its outstanding senior secured indebtedness.